+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rimantadine"

Antivirals Global Market Report 2024 - Product Thumbnail Image

Antivirals Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Influenza Medication - Global Strategic Business Report - Product Thumbnail Image

Influenza Medication - Global Strategic Business Report

  • Report
  • May 2024
  • 196 Pages
  • Global
From
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Rimantadine is an antiviral drug used to treat and prevent influenza A, a type of infectious disease. It is an adamantane derivative, and works by blocking the M2 protein, which is an ion channel that helps the virus to enter the host cell. It is available in both oral and intravenous forms, and is used to treat mild to moderate cases of influenza A. It is also used to prevent the spread of the virus in high-risk populations, such as the elderly and those with weakened immune systems. Rimantadine is generally well-tolerated, with few side effects. However, it is not effective against influenza B, and is not recommended for use in children under the age of two. The rimantadine market is a small but important part of the infectious diseases drugs market. It is used to treat and prevent influenza A, and is an important tool in the fight against the spread of the virus. Some companies in the rimantadine market include GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more